PPARG and Insulin resistance: Heterozygous LoF in PPARG has previously been linked to familial partial lipodystrophy, characterised by the loss of subcutaneous fat from the extremities and metabolic abnormalities such as insulin resistance and hypertriglyceridemia 24–27.